Professor Stephanie Amiel is RD Lawrence Professor of Diabetic Medicine at King’s College London, and a consultant physician to the diabetes services of King’s College Hospital NHS Foundation Trust.
Her academic and research interests have earned her global recognition; these include: hypoglycaemia in diabetes, metabolic neuroimaging, brain insulin sensitivity/resistance, and central responses to eating. Professor Amiel has served on grant review committees for Diabetes UK, the European Federation for the Study of Diabetes, and the Juvenile Diabetes Research Foundation UK Medical Advisory Committee and was the first chairman of the UK’s National Dose Adjustment For Normal Eating (DAFNE) Executive Committee, a post she held for 10 years. She has just completed chairing the Guideline Develolpment Group reviewing the diagnosis and management of adults with type 1 diabetes for the UK’s National Institute of Clinical Excellence (NICE). The guideline was published in August this year. She has added her expertise to several editorial boards including a spell as Editor of Diabetic Medicine, and has been awarded a number of honors including the Hellmut Mehnert Award at the International Diabetes Federation World Congress in 2009.
Pablo Aschner is Associate Professor of Endocrinology at the Javeriana University School of Medicine. At present he is also Director of Research at the San Ignacio University Hospital and Scientific Director of the Colombian Diabetes Association, Bogotá.
Professor Aschner’s main research interests include diagnosis, control and treatment of diabetes, epidemiology of diabetes and its complications as well as the metabolic syndrome in Latin America and the role of diabetes associations in primary health care. He has authored, or co-authored, over 90 abstracts, articles and book chapters in the field of diabetes research. He is a member of numerous societies including the Latin American Diabetes Association, and the Pan-American Endocrine Society. He served as a member of the WHO Expert Advisory Panel on chronic degenerative diseases and the WHO Ad Hoc Diabetes Reporting Group. He is a past President of the Colombian Endocrine Society, the Latin American Diabetes Association and the Latin American Diabetes Epidemiology Group. He also serves currently as chair of the IDF taskforce on Guidelines and Faculty member of the WHO/IDF/EASD Cambridge Diabetes Seminar and the Latin American Diabetes Epidemiology Course.
APRN, BC-ADM, CDE
Belinda Childs is Executive Director and a Diabetes Clinical Nurse Specialist at Great Plains Diabetes. She is also an adjunct faculty member in the Department of Nursing at Wichita State University.
Mrs. Childs served as editor for Diabetes Spectrum from 2001 to 2005, is the editor of The Complete Nurses Guide to Diabetes Care, and has authored several publications. She is a member of American Association of Diabetes Educators, the American Nurses Association, Sigma Theta Tau, and the American Diabetes Association (where she is a past president of Health Care & Education). Mrs. Childs is the 2010 recipient of the American Diabetes Association’s Outstanding Educator in Diabetes Award and the 1997 recipient of the American Diabetes Association Dr. Rachmiel Levine Award. She also served on the 2005 ADA Advisory Panel on hypoglycemia.
Philip E. Cryer
Prof Philip Cryer is an influential figure and world renowned expert in the field of hypoglycemia. He is Professor of Medicine Emeritus at Washington University in St. Louis.
A clinical investigator, Professor Cryer has studied the pathophysiology of glucose counter-regulation, and its relation to clinical hypoglycemia in people with diabetes for nearly four decades. Professor Cryer’s research has been recognized by his being the recipient of: the Banting Medal for Scientific Achievement of the American Diabetes Association; the Claude Bernard Medal of the European Association for the Study of Diabetes, an honorary doctorate from the University of Copenhagen, a MERIT award from the National Institutes of Health and, most recently, the Novartis Prize for Longstanding Achievement in Diabetes. A past president of the American Diabetes Association and a former editor of its leading journal, Diabetes, Professor Cryer has published his third book,
Hypoglycemia in Diabetes: Pathophysiology, Prevalence and Prevention.
The themes of Professor Cryer’s translational research are studies of the physiology of glucose counterregulation – the mechanisms that normally prevent or rapidly correct hypoglycemia – and of its pathophysiology in type 1 and type 2 diabetes, and the relationship of the latter to clinical hypoglycemia in diabetes.
Brian M Frier
Brian Frier is Honorary Professor of Diabetes in the University of Edinburgh and was previously Consultant Physician in general (internal) medicine and diabetes at the Royal Infirmary of Edinburgh.
Professor Frier was the Chair of Honorary Medical Advisory Panel on Driving and Diabetes to the Secretary of State for Transport from 2001 to 2012. He was also Vice-President, Royal College of Physicians of Edinburgh Chair of international Programme Panel for the global series of diabetes conferences called “Take Control, Peaks and Valleys”. He is an international authority on hypoglycaemia and invited speaker at many national and international diabetes conferences. Professor Frier has been a mentor and supervisor for 18 post-graduate medical graduates as clinical research fellows.
Bastiaan de Galan
Dr. de Galan is currently (2009 to present) the editor of the Dutch Journal of Diabetology and has served as an internist at the non-profit Radboud University Nijmegen Medical Centre for over 12 years.
Dr. de Galan’s expertise and general research interests include diabetes, epidemiology, clinical research and public health. He has published scientific journal articles in several subjects including altered cerebral metabolism during hypoglycaemia, steady state brain glucose concentrations during hypoglycaemia and the pharmacokinetic and pharmacodynamics considerations of insulin administration using needle-free injection technology.
Dr. Linda Gonder-Frederick is an Associate Professor in the Department of Psychiatry and Neurobehavioral Sciences at the University of Virginia, as well as Clinical Director and Training Director of the Behavioral Medicine Center.
Dr Gonder-Frederick’s early research focused on ability to recognize blood glucose extremes in people with type 1 diabetes, the impact of hypo- and hyperglycaemia on mood states, and the development of Blood Glucose Awareness Training with her colleagues Dr. Daniel Cox and Dr. William Clarke. Her research has also focused on fear of hypoglycaemia in patients and their families, the cognitive effects of hypo- and hyperglycaemia, and the development/testing of internet-delivered psychobehavioral interventions for a wide variety of issues relevant to diabetes, including blood glucose awareness, driving safety, pregnancy outcome, and reduction of glycemic risk parameters.
Additionally, Dr. Gonder-Frederick is working with the University of Virginia Artificial Pancreas team on the psychological and behavioral implications relevant to patient adoption and use of diabetes technologies, including continuous glucose monitoring and closed-loop therapy. Her research interests include behavioral and psychological issues in diabetes, hypoglycaemia, predictors of outcome of weight reduction surgery and development of patient interventions.
BA, MB, BChir, DM, FRCP
Professor Simon Heller is Professor of Clinical Diabetes at the University of Sheffield, UK, and Director of Research and Development and Honorary Consultant Physician at Sheffield Teaching Hospitals Foundation Trust.
Professor Heller’s current research interests include the physiologic responses to hypoglycaemia and hypoglycaemia unawareness, pathophysiologic mechanisms of sudden death in type 1 diabetes and the development of interventions to encourage more effective diabetes self-management. Professor Heller has authored over 200 original research articles and reviews.
Professor Heller was Editor in Chief of Diabetic Medicine between 2000 and 2004. He is currently a member of the NIHR Clinical Trials and Evaluation Panel, Juvenile Diabetes Research Foundation (JDRF) International Medical Scientific Review Committee, as well as the National Clinical Diabetes Lead of the NIHR Clinical Research Networ in the UK.
MBBS, DCH, FRACP, MD
Clinical Professor Tim Jones is the Head of the Diabetes & Obesity Research Team at the University of Western Australia.
PhD, MD, FRCGP, FRCP
Kamlesh Khunti is Professor of Primary Care Diabetes and Vascular Medicine at the University of Leicester.
MD, FRCPC, FACP, FACE, FAHA
Dr. Lawrence A. Leiter is Director of the Lipid Clinic; Associate Director of the Clinical Nutrition and Risk Factor Modification Centre; and Associate Scientist, Li Ka Shing Knowledge Institute at St. Michael’s Hospital in Toronto where he was also the Head of the Division of Endocrinology and Metabolism from 2000-2010.
Dr. Leiter has several research interests including clinical trials on the prevention of atherosclerosis, especially in diabetes, and the dietary and pharmacologic treatment of diabetes mellitus, hyperlipidemia, hypertension, and obesity. He has over 500 publications in peer-reviewed journals. He was an investigator in many of the landmark diabetes trials including the DCCT, ACCORD, and ADVANCE and is on the Steering Committees of many ongoing outcome trials in both the diabetes and lipid areas.
Dr. Leiter is the Past-President of the Canadian Society of Endocrinology & Metabolism (CSEM) and is a past Chair of the Clinical and Scientific Section of the Canadian Diabetes Association (CDA). He has been involved in many national and international committees and consensus conferences including those of the International Diabetes Federation, CDA, Canadian Hypertension Education Program (CHEP), Canadian Cardiovascular Society (Dyslipidemia), and Obesity Canada.
For his work, he has received a number of awards including the CDA Frederick G. Banting Award and the American Diabetes Association Charles H Best Award (awarded to DCCT investigators), both for Distinguished Service, the 2005 CSEM Educator of the Year Award, and the 2006 CDA Gerald S. Wong Award in recognition of significant contributions to the diabetes community. He was also the inaugural winner of the St. Michael’s Hospital Complete Physician Award in 2009.
Yingying Luo is an associate professor at Peking University People’s Hospital. She obtained her medical doctor degree from Peking University in 2008.
Munehide Matsuhisa is a Professor and current Director in Diabetes Therapeutic and Research Center, Institute of Advanced Medical Sciences, at Tokushima University.
Dr Matsuhisa is an involved and active member of the diabetes community. He is currently the president of the Tokushima Diabetes Association and is a chairperson for the Committee for Surveys on Severe Hypoglycaemia in the Japan Diabetes Society. He is a member of numerous professional associations including the American Diabetes Association, Asian Association for the Study of Diabetes and Japan Society for the Study of Obesity.
Rory J McCrimmon
MBChB, MD, FRCP
Professor Rory McCrimmon trained at the University of Edinburgh and completed his clinical and speciality training in Scotland.
In addition to his work in research and clinical practice, Prof McCrimmon serves on the editorial board of Diabetologia, Diabetes Care and the Journal of Clinical Endocrinology and Metabolism. He also serves as a member of the Medical Research Council Clinical Fellowship Training and Career Development Awards Panel, the Scottish Translational Medicine Training Initiative, Diabetes Research & Wellness Foundation, and Diabetes UK Harry Keen Intermediate Clinical Fellowship panel
Ulrik Pedersen-Bjergaard is Chief Physician at the Department of Cardiology, Nephrology and Endocrinology, Nordsjællands University Hospital Hillerød and Professor at the University of Copenhagen, Denmark.
He has delivered numerous oral educational presentations about endocrinology, particularly diabetes, for medical doctors, other health care professionals, patients and their relatives. He has published extensively and contributed to the current knowledge of hypoglycaemia and use of insulin analogues in clinical practice.
Dr. Elizabeth Seaquist is Professor of Medicine and Director, Division of Endocrinology and Diabetes in the Department of Medicine at the University of Minnesota Medical School, where she also holds the Pennock Family Chair in Diabetes Research.
Awards recognizing Dr. Seaquist’s research and mentoring include the American Diabetes Association Distinguished Clinical Scientist Award and the Mary Jane Kugel Award (from the Juvenile Diabetes Research Foundation), as well as multiple teaching and mentorship awards. Dr Seaquist also served as the President of the American Diabetes Association in 2014.
Dr. Seaquist is board certified in Internal Medicine and Endocrinology, Diabetes, and Metabolism. She holds a Bachelor of Arts degree from Vassar College in Poughkeepsie, New York, and a Medical Doctorate from the University of Minnesota in Minneapolis.
MBBS, FRACP, PhD
Professor Sophia Zoungas is an academic endocrinologist. She holds the Professorial Chair of Diabetes, Vascular Health and Ageing and is the Deputy Director of the Monash Centre for Health Research and Implementation, School of Public Health and Preventive Medicine, Monash University.
Prof Zoungas is the current President Elect of the Australian Diabetes Society, Chair of the National Association for Diabetes Centres and a Senior Medical Advisor to Diabetes Australia and the Australian Institute for Health and Welfare. She has over 100 publications, as well as over 4300 citations, 2 first author publications in the New England Journal of Medicine. She has received a number of key awards including the Monash Health rising star and Monash University research awards. Prof Zoungas was the international clinical director of the ADVANCE-ON study and currently leads the NHMRC funded StaREE clinical trial which will examine the effect of statin therapy on healthy and independent living elders.